Trial
NCT03840343
Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Mayo Clinic
Collaborators
Regenerative Medicine Minnesota
Condition
Diabetic Kidney Disease
Intervention
Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Lower Dose
Why stopped
Principal Investigator relocation
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-08-17